Nearly 4 in 10 American adults are estimated to have a liver condition that can lead to serious complications and even death.

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

As well as shedding pounds and controlling diabetes, Ozempic and Wegovy can help you drink less, researchers suggest ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

which involved around 800 patients treated with semaglutide or placebo on top of standard care and followed for 72 weeks. MASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

“We’re engaged in multiple post-marketing clinical trials in fatty liver disease, heart failure ... Ferozsons is also producing semaglutide, a biological molecule commonly used in another ...

is the most severe form of metabolic dysfunction-associated steatotic liver disease (MASLD), which in turn has been rebranded from non-alcoholic fatty liver disease (NAFLD). According to ...

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for ...